Health
Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis – News-Medical.net
Human dihydroorotate dehydrogenase(DHODH) is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis(RA),…
Human dihydroorotate dehydrogenase(DHODH) is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis(RA), psoriasis andmultiple sclerosis(MS).
The authors designed and synthesized a series of acrylamide-based novel DHODH inhibitors as potential RA treatment agents. 2-Acrylamidobenzoic acid analog11was identified as the lead compound for structure-activity relationship (SAR) studies.
The replacement of thephenyl group with naphthylmoieties…
-
General19 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business18 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General22 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General18 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts